Atezolizumab, an immune checkpoint inhibitor, caused precedent depressive symptoms related to limbic encephalitis

Psychiatry Clin Neurosci. 2022 Apr;76(4):125-126. doi: 10.1111/pcn.13325. Epub 2022 Feb 7.

Authors

Shuhei Wada¹, Kunihiro Iwamoto¹, Norio Ozaki¹

Affiliation

¹ Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.

PMID: 34967076
DOI: 10.1111/pcn.13325

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Depression
Humans
Immune Checkpoint Inhibitors*
Limbic Encephalitis*

Substances

Antibodies, Monoclonal, Humanized
Immune Checkpoint Inhibitors
atezolizumab